MACROLIDES AND PROTEASE INHIBITORS - ERYTHROMYCIN WITH AMPRENAVIR OR FOSAMPRENAVIR
The manufacturers say that both amprenavir and erythromycin levels may be increased on concurrent use. Fosamprenavir is predicted to interact similarly.
Monitor the outcome carefully. Advise patients to be alert for erythromycin and amprenavir or fosamprenavir adverse effects (e.g. gastrointestinal effects, tremors).
Monitor the outcome carefully. Advise patients to be alert for erythromycin and amprenavir or fosamprenavir adverse effects (e.g. gastrointestinal effects, tremors).